Kurebe M, Yokota M, Yuda Y, Sasaki H, Niizato T, Watanabe H, Hayasaka H
Jpn J Antibiot. 1984 May;37(5):855-89.
In this subacute study, male and female rats were administered with 100, 200, 400, 800 and 1,600 mg/kg/day of MT-141 through an intramuscular (i.m.) route or with 50, 100, 200, 400 and 800 mg/kg/day through an intravenous (i.v.) route for 30 days. MT-141 did not cause lethal effect on male and female rats even at the high dosage of 1,600 mg/kg/day i.m. (approx. one-6th of LD50) and 800 mg/kg/day i.v. (approx. one-8th of LD50). Histopathological findings revealed that MT-141 induced slight local irritation at the sites of i.m. and i.v. injection. Only at a high dose of 1,600 mg/kg/day i.m., MT-141 reduced significantly the gain of body weight in male rats, which was closely related to the decrease of food intake. A slight decrease in serum Cr. and Glc. was observed in male rats at the doses more than 200 mg/kg/day i.m. and a slight decrease of liver weight at the doses more than 800 mg/kg/day i.m., while a slight increase of serum CPK, GOT, A1-P and LDH was perceived at the doses more than 800 mg/kg/day i.m. The distention of cecum was induced by the doses more than 400 mg/kg/day i.m. but histopathological findings revealed no abnormality in the cecum. These results suggest that MT-141 at the dosage level of 1,600 mg/kg/day i.m. causes nonspecific slight toxicity based on the disturbance of nourishment in male rats. In female rats given 100 to 1,600 mg/kg/day i.m., MT-141 at the high doses induced a slight increase of serum GOT, LDH and CPK and distention of the cecum. It is assumed from these results that MT-141 at the dosage level of 1,600 mg/kg/day causes nonspecific slight toxicity in female rats. In male rats given 50 to 800 mg/kg/day through an i.v. route, the level of serum Glc. and Cr. and the liver weight slightly decreased at the doses more than 200 mg/kg/day i.v. The cecum distended at the doses more than 100 mg/kg/day i.v. The dose of 800 mg/kg/day i.v. increased the activity of LDH and CPK in the serum. In female rats, MT-141 raised slightly the level of serum GOT, A1-P, LDH and CPK even at the doses more than 400 mg/kg/day i.v., reduced the liver weight at the dose of 800 mg/kg/day i.v. and distended the cecum at the all doses. These results suggest that MT-141 at the dosage level of 800 mg/kg/day i.v. induces nonspecific slight toxicity in male and female rats.(ABSTRACT TRUNCATED AT 400 WORDS)
在这项亚急性研究中,雄性和雌性大鼠通过肌肉注射途径给予100、200、400、800和1600毫克/千克/天的MT - 141,或通过静脉注射途径给予50、100、200、400和800毫克/千克/天,持续30天。即使在1600毫克/千克/天肌肉注射(约为半数致死量的六分之一)和800毫克/千克/天静脉注射(约为半数致死量的八分之一)的高剂量下,MT - 141对雄性和雌性大鼠也未产生致死作用。组织病理学结果显示,MT - 141在肌肉注射和静脉注射部位引起轻微的局部刺激。仅在1600毫克/千克/天肌肉注射的高剂量下,MT - 141显著降低了雄性大鼠的体重增加,这与食物摄入量的减少密切相关。在肌肉注射剂量超过200毫克/千克/天的雄性大鼠中,观察到血清肌酐和葡萄糖略有下降,在肌肉注射剂量超过800毫克/千克/天的情况下,肝脏重量略有下降,而在肌肉注射剂量超过800毫克/千克/天的情况下,血清肌酸磷酸激酶、谷草转氨酶、碱性磷酸酶和乳酸脱氢酶略有升高。肌肉注射剂量超过400毫克/千克/天可导致盲肠扩张,但组织病理学结果显示盲肠无异常。这些结果表明,1600毫克/千克/天肌肉注射剂量的MT - 141基于对雄性大鼠营养的干扰而引起非特异性轻微毒性。在肌肉注射给予100至1600毫克/千克/天的雌性大鼠中,高剂量的MT - 141导致血清谷草转氨酶、乳酸脱氢酶和肌酸磷酸激酶略有升高以及盲肠扩张。从这些结果推测,1600毫克/千克/天剂量的MT - 141在雌性大鼠中引起非特异性轻微毒性。在通过静脉注射途径给予50至800毫克/千克/天的雄性大鼠中,静脉注射剂量超过200毫克/千克/天时,血清葡萄糖和肌酐水平以及肝脏重量略有下降。静脉注射剂量超过100毫克/千克/天时盲肠扩张。800毫克/千克/天静脉注射剂量增加了血清中乳酸脱氢酶和肌酸磷酸激酶的活性。在雌性大鼠中,即使静脉注射剂量超过400毫克/千克/天,MT - 141也会使血清谷草转氨酶、碱性磷酸酶、乳酸脱氢酶和肌酸磷酸激酶水平略有升高,800毫克/千克/天静脉注射剂量会降低肝脏重量,并且所有剂量都会使盲肠扩张。这些结果表明,800毫克/千克/天静脉注射剂量的MT - 141在雄性和雌性大鼠中诱导非特异性轻微毒性。(摘要截断于400字)